Osborne Clarke has advised Genome Diagnostics B.V. (GenDx) on its €135 million takeover by Eurobio Scientific.
Osborne Clarke in Amsterdam has advised the shareholders of Genome Diagnostics B.V. (GenDx), a leading HLA diagnostics company, in the...
Published on
24/08/2022
Read time
1m